Drug-induced lung disease adverse effect with Ledipasvir Acetonate/Sofosbuvir

• Autors principals: Sachiko Omotani (Autor), Toshihiko Ishizaka (Autor), Miki Inoue (Autor), Koji Nishida (Autor), Yukako Yasui (Autor), Yasutoshi Hatsuda (Autor), Junji Mukai (Autor), Michiaki Myotoku (Autor)
• Format: Llibre
• Publicat: BMC, 2020-04-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Abstract Background Interferon and ribavirin have been used as therapeutic agents for chronic hepatitis C infection or C-compensated cirrhosis in the conventional treatment. Hepatitis C virus (HCV) -specific direct-acting antiviral agents that directly inhibit the growth process of HCV have been app...